Evidence map›Paper›PMID 38391627›Full record

ArticleBioengineering (Basel, Switzerland)2024

Proactive Decision Support for Glaucoma Treatment: Predicting Surgical Interventions with Clinically Available Data.

Mark Christopher, Ruben Gonzalez, Justin Huynh, Evan Walker, Bharanidharan Radha Saseendrakumar, Christopher Bowd, Akram Belghith, Michael H Goldbaum, Massimo A Fazio, Christopher A Girkin and 5 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Meeting Challenges in the Diagnosis and Treatment of Glaucoma.Bioengineering (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Big data in visual field testing for glaucoma.Taiwan journal of ophthalmology
    Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mark ChristopherHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.
Ruben GonzalezHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.
Justin HuynhHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.ORCID 0000-0002-4640-6124
Evan WalkerHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.
Bharanidharan Radha SaseendrakumarHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.
Christopher BowdHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.
Akram BelghithHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.
Michael H GoldbaumHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.
Massimo A FazioDepartment of Ophthalmology and Vision Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.ORCID 0000-0002-7489-089X
Christopher A GirkinDepartment of Ophthalmology and Vision Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Carlos Gustavo De MoraesBernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Medical Center, New York, NY 10032, USA.
Jeffrey M LiebmannBernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Medical Center, New York, NY 10032, USA.
Robert N WeinrebHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.ORCID 0000-0001-9553-3202
Sally L BaxterHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.ORCID 0000-0002-5271-7690
Linda M ZangwillHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, CA 92037, USA.

Funding

Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Dirk-Uwe G Bartsch · 2012 to 2026
$10.3M
Ophthalmology and Visual Sciences Career Development K12 ProgramK12EY024225 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEINREB, ROBERT N · 2015 to 2025
$4.3M
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography AngiographyR01EY029058 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEINREB, ROBERT N · 2018 to 2024
$4.2M
African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the lamina cribrosa in progressionR01EY026574 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FAZIO, MASSIMO ANTONIO, GIRKIN, CHRISTOPHER ANTHONY · 2017 to 2020
$2.6M
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minoritiesR01MD014850 · NIMHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI COLEMAN, TODD P, WEINREB, ROBERT N · 2021 to 2024
$2.1M
Multi-modal Health Information Technology Innovations for Precision Management of GlaucomaDP5OD029610 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAXTER, SALLY LIU · 2020 to 2024
$2.1M
Multimodal Artificial Intelligence to Predict Glaucomatous Progression and Surgical InterventionR01EY034146 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAXTER, SALLY LIU, CHRISTOPHER, MARK · 2022 to 2025
$1.8M
Deep Learning Approaches to Detect Glaucoma and Predict Progression from Spectral Domain Optical Coherence TomographyR00EY030942 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHRISTOPHER, MARK · 2023 to 2025
$747k
AI-Based Identification of Rapid Glaucoma Progression to Guide Clinical Management and Accelerate Clinical TrialsR41EY034424 · NEI · AISIGHT HEALTH, INC. · PI TAFRESHI, ALI, ZANGWILL, LINDA M · 2022 to 2022
$240k
Short-Term Research training In Vision and Eye health (STRIVE)T35EY033704 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jolene Rudell, LINDA M ZANGWILL · 2022 to 2026
$144k
NEI NIH HHS K12 EY024225NEI NIH HHS P30 EY022589NEI NIH HHS R00 EY030942NEI NIH HHS R01 EY026574NEI NIH HHS R01 EY029058NEI NIH HHS R01EY029058, R01MD014850, K12EY024225, R00EY030942, DP5OD029610, R01EY034146, R41EY034424, T35EY033704, P30EY022589NEI NIH HHS R01 EY034146NEI NIH HHS R41 EY034424NEI NIH HHS T35 EY033704NIH HHS DP5 OD029610NIMHD NIH HHS R01 MD014850
6 · The paper itself

Abstract

A longitudinal ophthalmic dataset was used to investigate multi-modal machine learning (ML) models incorporating patient demographics and history, clinical measurements, optical coherence tomography (OCT), and visual field (VF) testing in predicting glaucoma surgical interventions. The cohort included 369 patients who underwent glaucoma surgery and 592 patients who did not undergo surgery. The data types used for prediction included patient demographics, history of systemic conditions, medication history, ophthalmic measurements, 24-2 VF results, and thickness measurements from OCT imaging. The ML models were trained to predict surgical interventions and evaluated on independent data collected at a separate study site. The models were evaluated based on their ability to predict surgeries at varying lengths of time prior to surgical intervention. The highest performing predictions achieved an AUC of 0.93, 0.92, and 0.93 in predicting surgical intervention at 1 year, 2 years, and 3 years, respectively. The models were also able to achieve high sensitivity (0.89, 0.77, 0.86 at 1, 2, and 3 years, respectively) and specificity (0.85, 0.90, and 0.91 at 1, 2, and 3 years, respectively) at an 0.80 level of precision. The multi-modal models trained on a combination of data types predicted surgical interventions with high accuracy up to three years prior to surgery and could provide an important tool to predict the need for glaucoma intervention.

Indexed as

deep learningglaucomaglaucoma progressionglaucoma surgerymachine learningOCTvisual field

Identifiers

PMID38391627
PMCPMC10886033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.